Sort
50,496 grants matching “lung cancer”
Project 2: Combined CAR-T cell therapy
$447,559Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratio
$447,526Stephen R. Bowen · University Of Washington · R01 · FY2019 · CA
Chemical Tools for Studying Fucosylated Glycans
$447,518Peng Wu · Scripps Research Institute, The · R01 · FY2017 · GM
Chemical Tools for Studying Fucosylated Glycans
$447,518Peng Wu · Scripps Research Institute, The · R01 · FY2019 · GM
Prevalence effects in visual research: Theoretical and practical implications
$447,500Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2023 · EY
Supplement: Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
$447,500Lydia Lynch · Brigham And Women'S Hospital · R01 · FY2020 · AI
Prevalence effects in visual research: Theoretical and practical implications
$447,500Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2020 · EY
Molecular Mechanisms of Complex Mixture Toxicity
$447,496Alvaro Puga · University Of Cincinnati · R01 · FY2014 · ES
Implications of metabolic heterogeneity on collective lung cancer cell invasion
$447,483Malathy (mala) Shanmugam · Emory University · R01 · FY2021 · CA
Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and Diagnosis
$447,482Ulas Bagci · Northwestern University At Chicago · R01 · FY2023 · CA
Developmental Funds
$447,466Joann B Sweasy · University Of Arizona · P30 · FY2022 · CA
Epidemiologic Studies of Germline Polymorphisms in miRNA Pathways: Risk of Lung Cancer Development and Recurrence
$447,453Xifeng Wu · Ut Southwestern Medical Center · P50 · FY2017 · CA
Epidemiologic Studies of Germline Polymorphisms in miRNA Pathways: Risk of Lung Cancer Development and Recurrence
$447,450Jack Roth · Ut Southwestern Medical Center · P50 · FY2018 · CA
Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications
$447,432Kamila Naxerova · Harvard Medical School · R37 · FY2024 · CA
Developmental transcription factors in Drosha-driven cancer
$447,405Kenneth Sung-Man Chen · Ut Southwestern Medical Center · R01 · FY2024 · CA
P2: Defining and Visualizing Effects of Costimulation on Antiviral Immunity
$447,374Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$447,367Aimee L Edinger · University Of California-Irvine · R01 · FY2023 · CA
High-Throughput De Novo Glycan Sequencing
$447,308Cheng Lin · Boston University Medical Campus · R01 · FY2022 · GM
High-Throughput De Novo Glycan Sequencing
$447,308Cheng Lin · Boston University Medical Campus · R01 · FY2021 · GM
High-Throughput De Novo Glycan Sequencing
$447,308Cheng Lin · Boston University Medical Campus · R01 · FY2020 · GM
Navajo Uranium Assessment and Kidney Health Project
$447,282Johnnye L Lewis · University Of New Mexico · R01 · FY2009 · ES
Behavioral Smoking Cessation Treatment for People Living with HIV/AIDS
$447,261David M Ledgerwood · Wayne State University · R01 · FY2016 · DA
Mechanistic evaluation of broccoli sprout extract in preclinical COPD models
$447,214Shyam Biswal · Johns Hopkins University · R01 · FY2014 · AT
Characterization of HER2 inhibitors with a novel mechanism of action
$447,195May H. Abdelaziz · University Of Texas Tyler · R15 · FY2024 · CA
PROSTATE, LUNG, COLORECTAL &OVARIAN CANCER
$447,194Georgetown University · N01 · FY2000 · CN